Saro Khemichian, M.D.

NPI 1811920242ActiveIndividual· Internal Medicine, Transplant Hepatology· Los Angeles, CA

Internal Medicine, Transplant Hepatology (M.D.) in Los Angeles, California, trained at University of Southern California Keck School of Medicine (class of 2003). Their prescriptions cost Medicare Part D more than their services did: $450,553 for 1,369 claims, against $65,973 paid for services in 2024. Gilead Sciences, Inc. reported $121.81 in payments in 2025, mostly food and beverage.

Overview

NPI	1811920242
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jul 9, 2006
Last updated in NPPES	Nov 27, 2023
Certified by provider	Oct 29, 2020

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Transplant Hepatology Primary	207RT0003X	A90035	CA
Internal Medicine	207R00000X	A90035	CA
Internal Medicine, Gastroenterology	207RG0100X	A90035	CA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Gastroenterology (CA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	316
Services billed	881 across 22 procedure codes
Paid by Medicare	$65,973

Part D prescriptions in 2024

Prescriptions (claims)	1,369 · 2,047 30-day fills
Patients	173
Total drug cost	$450,553
Generic share	87% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Southern California Keck School of Medicine
Graduation year	2003
Medicare specialty	Gastroenterology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth